Literature DB >> 11148660

Chemotherapy of brain tumors.

E Galanis1, J C Buckner.   

Abstract

This is a review of chemotherapy options for patients with brain tumors, both at the time of initial diagnosis and at recurrence. Gliomas, the most common malignant brain tumors, represent the main focus of the review; chemotherapeutic options for supratentorial, brain stem, and optic track gliomas are discussed.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11148660     DOI： 10.1097/00019052-200012000-00002

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN： 1350-7540            Impact factor:   5.710


  4 in total

1.  A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.

Authors:  Steven A Limentani; Anthony Asher; Michael Heafner; Joseph W Kim; Robert Fraser
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

2.  Outcome and prognostic factors of childhood diffuse brainstem glioma.

Authors:  Semie Hong; Il Han Kim; Kyu Chang Wang
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

3.  Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.

Authors:  Manuel Gómez-Río; Antonio Rodríguez-Fernández; Carlos Ramos-Font; Escarlata López-Ramírez; José Manuel Llamas-Elvira
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-03       Impact factor: 9.236

4.  Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors.

Authors:  Aleksandra Ellert-Miklaszewska; Iwona Anna Ciechomska; Bozena Kaminska
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.